Gene Therapy of Cancer : Methods and Protocols /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Totowa, NJ :
Humana Press : Imprint: Humana,
2009.
|
| Edición: | 2nd ed. 2009. |
| Colección: | Methods in Molecular Biology,
542 |
| Materias: |
Tabla de Contenidos:
- Experimental Approaches in Cancer Gene Therapy: Introduction
- The Development of Gene Therapy: From Monogenic Recessive Disorders to Complex Diseases Such as Cancer
- Vectorology for Cancer Gene Therapy
- Designing Adenoviral Vectors for Tumor-Specific Targeting
- Analysis of HSV Oncolytic Virotherapy in Organotypic Cultures
- Use of Minicircle Plasmids for Gene Therapy
- Transposable Elements as Plasmid-Based Vectors for Long-Term Gene Transfer into Tumors
- Designing Plasmid Vectors
- Development of Bacterial Vectors for Tumor-Targeted Gene Therapy
- Nonviral Transfer Technologies in Cancer Gene Therapy
- Electroporative Gene Transfer
- Gene Gun Delivery Systems for Cancer Vaccine Approaches
- Ultrasound-Mediated Gene Transfection
- Nonviral Jet-Injection Technology for Intratumoral In Vivo Gene Transfer of Naked DNA
- Experimental Studies in Cancer Gene Therapy
- Methods for Constructing and Evaluating Antitumor DNA Vaccines
- Immunity of Lentiviral Vector-Modified Dendritic Cells
- Saporin Suicide Gene Therapy
- Using In Vivo Biopanning for the Development of Radiation-Guided Drug Delivery Systems
- Chemosensitization of Tumor Cells: Inactivation of Nuclear Factor-Kappa B Associated with Chemosensitivity in Melanoma Cells After Combination Treatment with E2F-1 and Doxorubicin
- Induction of Tumor Cell Apoptosis by TRAIL Gene Therapy
- Silencing Epidermal Growth Factor Receptor by RNA Interference in Glioma
- Delivery of Phosphorodiamidate Morpholino Antisense Oligomers in Cancer Cells
- Use of RNA Aptamers for the Modulation of Cancer Cell Signaling
- G-Rich Oligonucleotides for Cancer Treatment
- Clinical Approaches in Cancer Gene Therapy - Requirements for Clinical Gene Therapy Trials
- Regulatory Aspects for Translating Gene Therapy Research into the Clinic
- Ethics of Cancer Gene Transfer Clinical Research
- Virus Production for Clinical Gene Therapy
- Production of Plasmid DNA as Pharmaceutical
- Clinical Protocols in Cancer Gene Therapy
- Gene Immunotherapy for Non-Small Cell Lung Cancer
- Gene Therapy for Antitumor Vaccination
- HSV-tk/IL-2 Gene Therapy for Glioblastoma Multiforme
- Construction and Characterization of an Oncolytic HSV Vector Containing a Fusogenic Glycoprotein and Prodrug Activation for Enhanced Local Tumor Control
- Newcastle Disease Virus: A Promising Vector for Viral Therapy, Immune Therapy, and Gene Therapy of Cancer
- Oncolytic Viral Therapy Using Reovirus
- Design and Testing of Novel Oncolytic Vaccinia Strains
- Tumor-Targeted Salmonella typhimurium Overexpressing Cytosine Deaminase: A Novel, Tumor-Selective Therapy
- Chemoprotection by Transfer of Resistance Genes
- Phase I Clinical Trial of Locoregional Administration of the Oncolytic Adenovirus ONYX-015 in Combination with Mitomycin-C, Doxorubicin, and Cisplatin Chemotherapy in Patients with Advanced Sarcomas.